相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Transgene optimization significantly improves SIN vector titers, gp91(phox) expression and reconstitution of superoxide production in X-CGD cells
B. Moreno-Carranza et al.
GENE THERAPY (2009)
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy
Eugenio Montini et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Self-inactivating gammaretroviral vectors for gene therapy of X-linked severe combined immunodeficiency
Susannah I. Thornhill et al.
MOLECULAR THERAPY (2008)
Physiological promoters reduce the genotoxic risk of integrating gene vectors
Daniela Zychlinski et al.
MOLECULAR THERAPY (2008)
Road to precision: recombinase-based targeting technologies for genome engineering
Dagmar Nov et al.
CURRENT OPINION IN BIOTECHNOLOGY (2007)
Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors
A. Schambach et al.
GENE THERAPY (2006)
Cell-culture assays reveal the importance of retroviral vector design for insertional genotoxicity
Ute Modlich et al.
BLOOD (2006)
A new generation of retroviral producer cells: Predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors
R. Schucht et al.
MOLECULAR THERAPY (2006)
The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: Predictability and efficiency by transgene exchange
A. S. Coroadinha et al.
JOURNAL OF BIOTECHNOLOGY (2006)
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration
Eugenio Montini et al.
NATURE BIOTECHNOLOGY (2006)
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1
MG Ott et al.
NATURE MEDICINE (2006)
Equal potency of gammaretroviral and lentiviral SIN vectors for expression of O6-methylguanine-DNA methyltransferase in hematopoietic cells
A Schambach et al.
MOLECULAR THERAPY (2006)
Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector
HB Gaspar et al.
LANCET (2004)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Vectors derived from simian immunodeficiency virus (SIV)
D Nègre et al.
BIOCHIMIE (2002)
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
A Aiuti et al.
SCIENCE (2002)
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement
E Verhoeyen et al.
HUMAN GENE THERAPY (2001)
Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors
A Schambach et al.
MOLECULAR THERAPY (2000)
The transgeneticist's toolbox:: Novel methods for the targeted modification of eukaryotic genomes
J Bode et al.
BIOLOGICAL CHEMISTRY (2000)
分享论文
